LEADER 01318nam0-2200373---450-
001 990009453450403321
005 20120411201822.0
035   $a000945345
035   $aFED01000945345
035   $a(Aleph)000945345FED01
035   $a000945345
100   $a20111017d1962----km-y0itay50------ba
101 1 $aita
102   $aIT
200 1 $aSieri, vaccini, anatossine, tubercoline nelle profilassi e terapia delle malattie infettive$fH.J. Parish, D.A. Cannon$gpresentazione del prof. A. De Barbieri$gtraduzione e note del prof. E. Cuboni
205   $a5. ed.
210   $aMilano$cIstituto sieroterapico milanese S. Belfanti$d1962
215   $a347 p.$cfig., fot$d21 cm
454  0$12001$aAntisera, toxoids, vaccine and tubercolins in prophylaxis and treatment$913740
610 0 $aImmunoterapia
676   $a615.37
700  1$aParish,$bH. J.$g<Henri James>$0509269
701  1$aCannon,$bD. A.$g<David Alexander>$0513551
702  1$aDe Barbieri,$bAugusto
702  1$aCuboni,$bEttore
801  0$aIT$bUNINA$gRICA$2UNIMARC
901   $aBK
912   $a990009453450403321
952   $aA VII 16/a$b1026$fDMVCM
952   $a43 F 8$bs.i.$fDMVAP
959   $aDMVAP
959   $aDMVCM
996   $aAntisera, toxoids, vaccine and tubercolins in prophylaxis and treatment$913740
997   $aUNINA